Peer Review | Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology | September 2, 2024 Share
Public Comment | Patient-Focused Drug Development: Core Patient-Reported Outcomes in Cancer Clinical Trials | August 2, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Laboratory Values | August 2, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Performance Status | August 2, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications | August 1, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Minimum Age Considerations for Inclusion of Pediatric Patients | August 1, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Patients with HIV, Hepatitis B Virus, or Hepatitis C Virus Infections | August 1, 2024 Share
Public Comment | Cancer Clinical Trial Eligibility Criteria: Patients with Organ Dysfunction or Prior or Concurrent Malignancies | August 1, 2024 Share
